AI, NVIDIA and supercomputer
Digest more
Eli Lilly reported higher profit and raised its outlook on surging demand for its weight-loss drugs, sending its shares ...
Eli Lilly shares surged after strong third-quarter results and a raised annual forecast, powered by booming demand for its ...
Both sales figures came in well ahead of analyst expectations and will heap pressure on Lilly's main rival in the GLP-1 ...
Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently provided insights on. Cramer highlighted it as the ...
Under the agreement, Lilly will gain control of Adverum’s lead product candidate, Ixo-vec, a Phase 3 gene therapy designed to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback